Skip to main content
. 2020 Apr 9;7(5):ofaa121. doi: 10.1093/ofid/ofaa121

Figure 1.

Figure 1.

Cumulative incidence curves of time to first infections in the first 28 days after CAR T-cell therapy. A–D, Cumulative incidences among all patients (n = 83) of any (A), bacterial (B), viral (C), and fungal (D) infections within 28 days after CTI. Dotted lines represent 95% confidence intervals. Death and loss to follow-up were treated as competing risks. Abbreviations: CAR, chimeric antigen receptor; CRS, cytokine release syndrome.